This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: Viridian Therapeutics, Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations of Peter Harwin in Thyroid Eye Disease Treatment
Introduction
Peter Harwin is an accomplished inventor based in Philadelphia, PA (US). He has made significant contributions to the field of medical treatments, particularly focusing on thyroid eye disease. His innovative work has led to the development of a patent that addresses critical health issues faced by patients.
Latest Patents
Peter Harwin holds a patent for "Compositions and methods for treatment of thyroid eye disease." This patent includes antibodies and compositions against Insulin-Like Growth Factor-1 Receptor (IGF-1R) and outlines methods for treating or reducing the severity of thyroid eye disease (TED). The invention aims to reduce proptosis and Clinical Activity Score (CAS) in subjects by inhibiting the activity of IGF-1R with these antibodies and compositions. He has 1 patent to his name, showcasing his dedication to advancing medical science.
Career Highlights
Peter Harwin is currently associated with Viridian Therapeutics, Inc., where he continues to work on innovative solutions for thyroid eye disease. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Peter has worked alongside talented colleagues such as Tomas Kiselak and Angela She. Their combined expertise fosters a collaborative environment that enhances the development of effective treatments.
Conclusion
Peter Harwin's contributions to the treatment of thyroid eye disease exemplify the impact of innovation in medicine. His patent and ongoing work at Viridian Therapeutics, Inc. highlight the importance of research and collaboration in addressing complex health challenges.